Weishuo Fang | Pharmacology | Research Excellence Award

Dr. Weishuo Fang | Pharmacology | Research Excellence Award

Principal Investigator | Institute of Materia Medica, CAMS & PUMC | China

Dr. Weishuo Fang is a pharmacology researcher specializing in medicinal chemistry, drug discovery, and molecular therapeutics. His work focuses on FXR modulators, neuroprotection, and anticancer drug development. With 1694 citations, 102 publications, and an h-index of 24, he has made significant contributions to translational and pharmaceutical research.

Citation Metrics

1800

1500

1200

900

600

300

0

Citations 1694

Documents
102

h-index
24

 

View Scopus Profile View ORCID Profile View Google Scholar Profile

 

Featured Publications

Farnesoid X receptor modulator represses liver fibrosis via ERK/p38 signaling pathways
– Toxicology Mechanisms and Methods, 2024
Modulation of taxane binding to tubulin improves microtubule targeting and anticancer activity
– European Journal of Medicinal Chemistry, 2023
Structure optimization of FXR modulators for NASH therapy
– Pharmaceuticals, 2023
Discovery of selective FXR modulators improving metabolic disorders
– Bioorganic Chemistry, 2022
Neuroprotective compound reducing amyloid-related cytotoxicity
– Neurochemical Research, 2020

Xingqi Zhao | Pharmacology | Excellence in Research Award

Dr. Xingqi Zhao | Pharmacology | Excellence in Research Award

Lecturer | Shandong Medical And Pharmaceutical University | China.

Dr. Xingqi Zhao is a Lecturer at Shandong Medical and Pharmaceutical University, China, with research focused on molecular biology, oxidative stress, and cellular repair mechanisms. His work explores epigenetic regulation and disease pathways, contributing to understanding tissue injury and recovery. With 93 citations, 8 publications, and an h-index of 5, his research shows emerging academic impact.

Citation Metrics

100

80

60

40

20

0

Citations
93

Documents
8

h-index
5

 

View Scopus Profile View ORCID Profile

 

Featured Publications

Corrigendum to “Symmetrical dimethylation of H4R3: A bridge linking DNA damage and repair upon oxidative stress”
– Redox Biology

MST Tahmina Akter | Drug Development | Women Researcher Award

MST Tahmina Akter | Drug Development | Women Researcher Award

Chiba Institute of Technology | Japan

Dr. MST Tahmina Akter is a researcher specializing in dental science, pharmacology, and molecular biology, with a strong focus on drug development and viral mechanisms, particularly HIV-1 and SARS-CoV-2. Her work integrates advanced molecular techniques, nucleic acid engineering, and therapeutic target analysis to support innovative treatment strategies. She has contributed to scientific literature with 3 peer-reviewed journal publications, 7 conference abstracts, and 3 poster presentations. Her research profile reflects growing academic impact with developing citation metrics, publications, and scholarly indexing indicators such as h-index, demonstrating her active engagement and contribution to interdisciplinary biomedical and translational research.

Citation Metrics

1000

800

600

400

200

0

Citations
2

document
3

h-index
1

Citations     i10-index     h-index

 

View ORCID Profile

 

Featured Publications

Elif Baris | Pharmacology | Excellence in Research Award

Assoc. Prof. Dr. Elif Baris | Pharmacology | Excellence in Research Award

İzmir University of Economics | Turkey

Elif Baris is an Assistant Professor of Medical Pharmacology at Izmir University of Economics, specializing in molecular pharmacology with a strong focus on inflammation, pain physiology, and cholinergic anti-inflammatory mechanisms. She holds a pharmacy degree and a doctoral qualification in medical pharmacology from Dokuz Eylül University, and has developed expertise in cytokine signaling, oxidative stress, neuroimmune modulation, molecular oncology, stem cell immunoregulation, and sepsis models. Her professional experience includes leading and contributing to numerous multidisciplinary research projects supported by national and institutional scientific bodies, alongside collaborations with prominent medical and biotechnology institutions. Her research interests extend to autonomic nervous system pharmacology, neuroimmune interactions, mechanotransduction through TRPV4 channels, and innovative drug repurposing strategies. She possesses strong research skills in qRT-PCR, Western blotting, ELISA, cytokine arrays, flow cytometry, and real-time cell analysis, supported by extensive publications in indexed journals and multiple patents involving varenicline- and choline-based therapeutic applications. She has received recognition through collaborative roles in funded research, chapter authorship in academic publications, and contributions to translational pharmacology. Her professional memberships include national societies in pharmacology and physiology, reflecting her commitment to scientific advancement. With her growing contributions to drug innovation, inflammation therapeutics, and molecular pharmacology, she continues to advance impactful research aimed at improving mechanisms of pain management and immune regulation.

Profile: Google scholar

Featured Publications

Baris, E., Efe, H., Gumustekin, M., Arici, M. A., & Tosun, M. (2021). Varenicline prevents LPS-induced inflammatory response via nicotinic acetylcholine receptors in RAW 264.7 macrophages. Frontiers in Molecular Biosciences, 8, 721533. [15 citations]

Baris, E., Simsek, O., Arici, M. A., & Tosun, M. (2023). Choline and citicoline ameliorate oxidative stress in acute kidney injury in rats. Bratislava Medical Journal / Bratislavské Lekárske Listy, 124(1). [12 citations]

Baris, E., Simsek, O., Efe, H., Oncu, S., Gelal, A., Hamurtekin, E., Tosun, M., … (2021). Effects of CDP-choline and choline on COX pathway in LPS-induced inflammatory response in rats. International Journal of Pharmacology, 17(2), 84–96. [10 citations]

Baris, E., Arici, M. A., & Tosun, M. (2024). Nicotinic acetylcholine receptor-mediated effects of varenicline on LPS-elevated prostaglandin and cyclooxygenase levels in RAW 264.7 macrophages. Frontiers in Molecular Biosciences, 11, 1392689. [4 citations]

 

Lucky Norah Katende-Kyenda | Pharmacy | Best Researcher Award

Assoc. Prof. Dr. Lucky Norah Katende-Kyenda | Pharmacy | Best Researcher Award

Walter Sisulu University | South Africa

Assoc. Prof. Dr. Lucky Norah Katende-Kyenda is an accomplished pharmacy scholar and Associate Professor in Pharmacology at Walter Sisulu University, with a strong academic foundation that includes a doctorate in Pharmacy Practice, multiple master’s degrees across pharmaceutical sciences, international primary healthcare and pharmacy practice, and a postgraduate diploma in education earned with distinction. Her professional experience spans advanced teaching, postgraduate supervision, curriculum moderation and extensive contributions as an external examiner for several leading universities, where she supports pharmacology and clinical pharmacy training. Her research interests centre on pharmacy practice, pharmacoepidemiology, public health, maternal health and gender-based violence, reflected in numerous peer-reviewed publications, book chapters and ongoing collaborative projects. She brings strong research skills in qualitative and quantitative methodology, pharmacological evaluation, evidence synthesis and community-focused health research. Her career includes invited talks, guest lectures, scientific presentations, and leadership roles at national and international conferences. She has received recognition for excellence in reviewing, academic service and research contributions, and continues to lead initiatives within human rights and gender-based violence research. Overall, she is a highly dedicated academic whose work advances pharmacology education, strengthens multidisciplinary health research and contributes meaningfully to community-centred healthcare improvement.

Profile: ORCID

Featured Publications

Chaoyue Huo | Pharmacology & Traditional Medicine | Women Researcher Award

Dr. Chaoyue Huo | Pharmacology & Traditional Medicine | Women Researcher Award

Beijing University of Chinese Medicine Third Affiliated Hospital | China

Huo Chaoyue is a dedicated PhD candidate in Gynecology at the Third Affiliated Hospital of Beijing University of Chinese Medicine, specialising in the study of endometriosis and complex gynaecologic disorders such as polycystic ovary syndrome, adenomyosis, and menopause. Her academic journey in Traditional Chinese Medicine has been entirely nurtured at Beijing University of Chinese Medicine, where she advanced through undergraduate and postgraduate studies to her current doctoral research. She possesses extensive clinical experience in gynaecological diagnosis and management, performing and interpreting procedures such as hysteroscopy, colposcopy, and ultrasound for thousands of patients annually. Her research integrates multi-omics approaches, network pharmacology, and mechanistic studies of herbal medicine, particularly focusing on the Hippo/YAP signalling pathway. She has achieved significant recognition as the first author of a Q1-ranked SCI publication in Phytomedicine and is leading ongoing real-world clinical research comparing herbal and conventional therapies for endometriosis. Skilled in molecular biology, animal experimentation, and advanced data analysis using SPSS, R, and Prism, she demonstrates strong interdisciplinary competence. Her innovative contributions have earned multiple provincial awards and national invention patents. Driven by curiosity and compassion, Huo Chaoyue continues to bridge Traditional Chinese Medicine and modern biomedical science to improve women’s reproductive health worldwide.

Profile: scopus

Featured Publications

Amalia Papanikolopoulou | Medicine and Dentistry | Best Research Article Award

Dr. Amalia Papanikolopoulou | Medicine and Dentistry | Best Research Article Award

Athens Naval Hospital | Greece

Dr. Amalia Papanikolopoulou is a distinguished Greek medical professional and researcher with a strong interdisciplinary background in medicine, pharmacy, and clinical pharmacology. She earned her PhD from the National and Kapodistrian University of Athens, where she also obtained master’s degrees in Clinical Pharmacy and Tumors of the Chest, and holds both medical and pharmacy degrees from the same institution. Her professional career bridges pharmacy and medicine, having served as a hospital pharmacist and head of pharmacology at Athens Medical Center before specializing as a resident doctor in internal medicine and hematology at major hospitals in Athens. Dr. Papanikolopoulou’s research interests encompass infectious diseases, antimicrobial resistance, pharmacogenomics, hematologic malignancies, and oncologic pharmacotherapy. She has participated in multiple international and national clinical trials as a study coordinator and has authored numerous peer-reviewed publications with a notable citation record and h-index, reflecting her scholarly impact. Her research skills include clinical data analysis, pharmacovigilance, infection control, and evidence-based therapeutic evaluation. Dr. Papanikolopoulou is an active member of several national and international medical and pharmacological societies and has received multiple awards for her contributions at Panhellenic conferences. Her professional journey exemplifies dedication to translational medicine, bridging clinical practice with research to advance patient care and therapeutic innovation.

Profile: ORCID

Featured Publications

Jaime Charris | Medicinal Chemistry | Best Researcher Award

Dr. Jaime Charris | Medicinal Chemistry | Best Researcher Award

Central University of Venezuela | Venezuela

Jaime Enrique Charris Charris is a distinguished medicinal chemist from the Faculty of Pharmacy at the Central University of Venezuela, recognized for his contributions to organic synthesis, drug design, and spectroscopic methods applied to the development of molecules with anticancer and antiparasitic potential. He holds academic training in pharmaceutical sciences, medicinal chemistry, and a doctoral degree in the same field, complemented by postdoctoral research experiences in leading institutions in the United States and France. His professional trajectory includes decades of service as a professor, researcher, and academic leader, where he directed divisions, postgraduate programs, and research initiatives within his faculty, eventually attaining emeritus status. His research interests focus on the design, synthesis, and biological evaluation of heterocyclic compounds, hybrids, and functionalized derivatives for the treatment of diseases such as Chagas, leishmaniasis, malaria, and various cancers, with skills spanning synthetic chemistry, in silico ADMET profiling, pharmacological assays, and drug repurposing strategies. He has guided doctoral research, secured national research grants, and published extensively in international journals. His work has been recognized with prestigious awards, including distinctions from scientific foundations, academic institutions, and national science ministries. In conclusion, Dr. Charris combines scientific rigor, innovation, and leadership in medicinal chemistry, positioning himself as a prominent figure advancing therapeutic discovery in Latin America and beyond.

Profile: Google scholar

Featured Publications

Levent Tumkaya | Medicine | Best Researcher Award

Prof. Dr. Levent Tumkaya | Medicine | Best Researcher Award

Ondokuz Mayis University | Turkey

Prof. Levent Tümkaya is a distinguished academic and medical researcher whose career reflects deep expertise in the field of basic medical sciences with a strong focus on cellular biology, physiology, and pathology. He completed his doctoral studies at Ondokuz Mayis University School of Medicine after earning his postgraduate degree at Recep Tayyip Erdogan University, where he developed a solid foundation in medical and life sciences. Over the course of his career, he has advanced from research assistant to assistant professor, associate professor, and later full professor, holding academic appointments at both Recep Tayyip Erdogan University and Ondokuz Mayis University. His research interests include the biological effects of electromagnetic fields, mechanisms of cellular damage and repair, radiotherapy-induced organ injury, reproductive health, and strategies for enhancing nutrient bioavailability. He has authored several scientific articles published in high-impact journals indexed in SCI and related databases, demonstrating his strong research skills in experimental design, histopathological analysis, and biomedical investigation. Prof. Tümkaya has received recognition through his extensive scholarly contributions and his active role in advancing medical research and education. His career reflects dedication to both teaching and scientific innovation, and his continuing work positions him as a leading scholar making significant contributions to medical science and public health.

Profile: ORCID

Featured Publications

Qura Ain | Phamagenetics | Women Researcher Award

Dr. Qura Ain | Phamagenetics | Women Researcher Award

University College Dublin | Pakistan

Dr. Qura Tul Ain is a passionate pharmacogenetic researcher and medical doctor with a strong dedication to advancing knowledge in rare diseases, human genetics, and advanced health sciences. She completed her MBBS from the Services Institute of Medical Sciences in Lahore, where she gained extensive clinical exposure through rotations in medicine, surgery, intensive care, gynecology, and ophthalmology, and later pursued an MPhil in Pharmacology with a specialization in molecular genetics at Shifa Tameer-e-Millat University, Islamabad. Her academic training provided her with expertise in genomics, bioinformatics, and molecular pharmacology, with her thesis focusing on the pharmacogenetics of low-dose empagliflozin in patients with heart failure. Professionally, she has served as a demonstrator in pharmacology at Shifa College of Medicine, alongside clinical roles as a medical officer and house physician in both medicine and surgical departments. Her research interests include pharmacogenomics, molecular genetics, and personalized medicine, with a particular focus on identifying genetic markers that predict treatment outcomes in cardiovascular diseases. She is skilled in laboratory techniques such as PCR, RFLP, DNA/RNA extraction, and gel electrophoresis, which support her translational research. Her contributions have been recognized through research fellowships and academic opportunities, reflecting her commitment to bridging genetics and clinical therapeutics. With her strong foundation in medicine, research, and teaching, Dr. Qura Tul Ain is well positioned to make impactful contributions to precision medicine and healthcare innovation.

Profile: ORCID

Featured Publications